Publication Author: Sullivan_Sean

• Showing outcomes and proving value brings success.

  Fullerton DS, Atherly D, Sullivan SD. Showing outcomes and proving value brings success. Manag Care Interface. 2001 Jun;14(6):63-5, 71.

  rakerr2

  June 1, 2001

• Cost and cost-effectiveness of universal screening for hearing loss in newborns.

  Kezirian EJ, White KR, Yueh B, Sullivan SD. Cost and cost-effectiveness of universal screening for hearing loss in newborns. Otolaryngol Head Neck Surg. 2001 Apr;124(4):359-67.

  rakerr2

  April 1, 2001

• Economic analysis of lung volume reduction surgery as part of the National Emphysema Treatment Trial. NETT Research Group.

  Ramsey SD, Sullivan SD, Kaplan RM, Wood DE, Chiang YP, Wagner JL. Economic analysis of lung volume reduction surgery as part of the National Emphysema Treatment Trial. NETT Research Group. Ann Thorac Surg. 2001 Mar;71(3):995-1002.

  rakerr2

  March 1, 2001

• The costs of treating COPD in the United States.

  Strassels SA, Smith DH, Sullivan SD, Mahajan PS. The costs of treating COPD in the United States. Chest. 2001 Feb;119(2):344-52.

  rakerr2

  February 1, 2001

• Health economics of asthma and rhinitis. II. Assessing the value of interventions.

  Sullivan SD, Weiss KB. Health economics of asthma and rhinitis. II. Assessing the value of interventions. J Allergy Clin Immunol. 2001 Feb;107(2):203-10. Review.

  rakerr2

  February 1, 2001

• The health economics of asthma and rhinitis. I. Assessing the economic impact.

  Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol. 2001 Jan;107(1):3-8. Review.

  rakerr2

  January 1, 2001

• Design issues for conducting cost-effectiveness analyses alongside clinical trials.

  Ramsey SD, McIntosh M, Sullivan SD. Design issues for conducting cost-effectiveness analyses alongside clinical trials. Annu Rev Public Health. 2001;22:129-41. Review.

  rakerr2

  January 1, 2001

• Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.

  Lee TA, Sullivan SD, Veenstra DL, Ramsey SD, Steger PJ, Malinverni R, Pleil AM, Williamson T. Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS. Pharmacoeconomics. 2001;19(5 Pt 2):535-50. Review.

  rakerr2

  January 1, 2001

• The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection.

  Saint S, Veenstra DL, Sullivan SD, Chenoweth C, Fendrick AM. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med. 2000 Sep 25;160(17):2670-5.

  rakerr2

  September 25, 2000

• Trends in the cost of illness for asthma in the United States, 1985-1994.

  Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol. 2000 Sep;106(3):493-9.

  rakerr2

  September 1, 2000